Enanta Pharmaceuticals Inc (ENTA)
10.05
-0.42
(-4.01%)
USD |
NASDAQ |
Sep 27, 16:00
10.02
-0.03
(-0.30%)
After-Hours: 20:00
Enanta Pharmaceuticals Cash from Operations (Quarterly): -14.78M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -14.78M |
| March 31, 2024 | -28.60M |
| December 31, 2023 | -24.99M |
| September 30, 2023 | -21.60M |
| June 30, 2023 | -32.13M |
| March 31, 2023 | -13.78M |
| December 31, 2022 | -35.64M |
| September 30, 2022 | -15.53M |
| June 30, 2022 | -29.60M |
| March 31, 2022 | -26.38M |
| December 31, 2021 | -13.27M |
| September 30, 2021 | -21.02M |
| June 30, 2021 | -29.51M |
| March 31, 2021 | -4.579M |
| December 31, 2020 | -14.89M |
| September 30, 2020 | -15.46M |
| June 30, 2020 | -4.488M |
| March 31, 2020 | 14.67M |
| December 31, 2019 | 12.36M |
| September 30, 2019 | 8.545M |
| June 30, 2019 | 2.533M |
| March 31, 2019 | 30.09M |
| December 31, 2018 | 30.25M |
| September 30, 2018 | 28.34M |
| June 30, 2018 | 4.048M |
| Date | Value |
|---|---|
| March 31, 2018 | -7.578M |
| December 31, 2017 | 4.409M |
| September 30, 2017 | 57.31M |
| June 30, 2017 | -4.796M |
| March 31, 2017 | -3.002M |
| December 31, 2016 | 3.145M |
| September 30, 2016 | -2.126M |
| June 30, 2016 | -2.112M |
| March 31, 2016 | 10.05M |
| December 31, 2015 | 29.99M |
| September 30, 2015 | -2.375M |
| June 30, 2015 | -14.20M |
| March 31, 2015 | 98.86M |
| December 31, 2014 | -5.61M |
| September 30, 2014 | -4.932M |
| June 30, 2014 | 35.11M |
| March 31, 2014 | -4.13M |
| December 31, 2013 | -5.871M |
| September 30, 2013 | -2.503M |
| June 30, 2013 | -5.922M |
| March 31, 2013 | 10.03M |
| December 31, 2012 | 9.045M |
| September 30, 2012 | -1.702M |
| June 30, 2012 | -3.828M |
| March 31, 2012 | 31.34M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-35.64M
Minimum
Dec 2022
14.67M
Maximum
Mar 2020
-15.53M
Average
-15.50M
Median
Cash from Operations (Quarterly) Benchmarks
| Ardelyx Inc | -19.40M |
| NovaBay Pharmaceuticals Inc | -0.578M |
| Palatin Technologies Inc | -8.607M |
| iBio Inc | -4.854M |
| Theriva Biologics Inc | -3.452M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -6.345M |
| Cash from Financing (Quarterly) | -6.647M |
| Free Cash Flow | -100.33M |
| Free Cash Flow Per Share (Quarterly) | -1.006 |
| Free Cash Flow to Equity (Quarterly) | -21.32M |
| Free Cash Flow to Firm (Quarterly) | -21.32M |
| Free Cash Flow Yield | -47.26% |